- Home
- GME vs SNN Comparison
GME vs SNN Comparison
Compare GME & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GME
- SNN
- Stock Information
- Founded
- GME 1996
- SNN 1856
- Country
- GME United States
- SNN United Kingdom
- Employees
- GME N/A
- SNN N/A
- Industry
- GME Electronics Distribution
- SNN Industrial Specialties
- Sector
- GME Consumer Discretionary
- SNN Health Care
- Exchange
- GME Nasdaq
- SNN Nasdaq
- Market Cap
- GME 10.1B
- SNN 10.8B
- IPO Year
- GME 2002
- SNN 1999
- Fundamental
- Price
- GME $26.57
- SNN $24.88
- Analyst Decision
- GME Sell
- SNN Strong Buy
- Analyst Count
- GME 1
- SNN 1
- Target Price
- GME $10.00
- SNN N/A
- AVG Volume (30 Days)
- GME 10.0M
- SNN 962.8K
- Earning Date
- GME 12-04-2024
- SNN 08-01-2024
- Dividend Yield
- GME N/A
- SNN 3.01%
- EPS Growth
- GME N/A
- SNN 39.77
- EPS
- GME 0.12
- SNN 0.35
- Revenue
- GME $4,552,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- GME N/A
- SNN $6.97
- Revenue Next Year
- GME N/A
- SNN $5.46
- P/E Ratio
- GME $213.46
- SNN $34.83
- Revenue Growth
- GME N/A
- SNN 5.48
- 52 Week Low
- GME $9.95
- SNN $23.65
- 52 Week High
- GME $64.83
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- GME 67.27
- SNN 32.09
- Support Level
- GME $22.81
- SNN $24.49
- Resistance Level
- GME $28.05
- SNN $25.09
- Average True Range (ATR)
- GME 1.56
- SNN 0.43
- MACD
- GME 0.46
- SNN -0.06
- Stochastic Oscillator
- GME 70.00
- SNN 19.77
About GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. GameStop sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.